Department of Pathology

The NYU School of Medicine, founded in 1841, has been a pioneer in the field of pathology since its inception, both through its earliest approaches for the dissection and study of human bodies and through the groundbreaking work of William Welch, who helped establish a laboratory for teaching the use of the microscope. In 1881 Welch was appointed Professor of Pathologic Anatomy and General Pathology, the first position of its kind in the country. Around the same time, a laboratory, devoted specifically to the study of the "pathology of many diseases," was founded through a gift from Andrew Carnegie at Bellevue Hospital Medical College. With its stated research focus, this laboratory became the first in the United States for teaching and investigation in pathology.

News

Congratulations to Dr. Margret Magid for her 2017 APC Michele D. Raible Distinguished Teaching Award in Undergraduate Medical Education. This award is made in recognition of Dr. Magid’s extraordinary contributions to undergraduate medical education and her stature as a nationally recognized pathology educator and leader. More

The American Board of Pathology (ABP) is pleased to announce the election of Dr. Barbara Sampson as a Trustee. Dr. Sampson has been the Chief Medical Examiner of the City of New York since December 2014 and is the first woman appointed to lead this Office. She is a Professor at the Department of Pathology. She earned her Bachelor’s degree at Princeton, a Ph.D. in Molecular Biology at Rockefeller University, her degree in medicine at Cornell University Medical College, and residency at Brigham and Women’s Hospital. She has published widely on forensic pathology and microbiology and serves as an Associate Editor of the journal Cardiovascular Pathology. Dr. Sampson is board certified in Anatomic and Clinical Pathology and Forensic Pathology.

More

Case of the Week

Week 9: Case 1: Cytopathology. The patient is a 35 year old HIV-positive male who presents to the emergency...
More

More

New Research

Acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS) are initiated and sustained by self-renewing malignant stem cells; thus, eradication of AML and MDS stem cells is required for cure. Christopher Y. Park, MD, PhD
More

MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis. Beatriz Aranda-Orgilles, Ph.D.
More

More